ADHD Medication Side Effects: Complete Guide to Common and Rare Side Effects
A comprehensive guide to ADHD medication side effects — appetite suppression, insomnia, anxiety, crash/rebound, and rare serious effects — with management strategies for each.
Get new titration guides by email
Occasional, evidence-based guides on medication tracking and titration — no noise.
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. ADHD medications are prescription-only and should be taken only under the supervision of a licensed healthcare provider. The side-effect rates quoted here come from the US prescribing information (the FDA label) for each medicine; individual experiences vary. Do not adjust, stop, or start any medication without consulting your prescriber. If you are experiencing a medical emergency, including chest pain, fainting, a seizure, or thoughts of self-harm, call emergency services immediately.
Table of Contents
- Why Side Effects Matter in Titration
- Common Side Effects by Drug Class
- Side Effects Reference Table by Medication
- Detailed Side Effect Guide
- Rare but Serious Side Effects
- When to Push Through vs. When to Contact Your Prescriber
- FAQ
- Key Takeaways
Why Side Effects Matter in Titration
Side effects during titration are common, and most of them are the expected ones listed on the label. The useful question is which kind you are dealing with:
- Early effects that some people find ease off over the first weeks
- Dose-related effects that your prescriber may be able to address by changing the plan
- Reactions that suggest a medicine or class may not suit you
- Serious events that need urgent medical attention
Memory is a poor record of how a dose felt two weeks ago. A short daily log of what you noticed and when gives you and your prescriber something concrete to look at, instead of a general impression.
This guide explains what each common side effect is, how often it showed up in the clinical trials behind each label, and when the label says to get help.
Common Side Effects by Drug Class
The tables below use the adult trial figures from each US label, shown as the rate on the medicine against the rate on placebo. Where a label only reports children, that is noted. A dash means the label does not report that effect in its common-reactions table for that group.
Amphetamine-Based Medications
Includes: Adderall (IR and XR), Vyvanse (lisdexamfetamine), Mydayis, Dexedrine, Evekeo, Zenzedi.
Amphetamines block the reuptake of dopamine and norepinephrine and also increase their release. Methylphenidate mainly blocks reuptake. That difference in mechanism is well described, but it does not tell you in advance which one a given person will tolerate better.
Most common in adult trials (medicine vs placebo):
| Side Effect | Adderall XR [1] | Vyvanse [2] |
|---|---|---|
| Dry mouth | 35% vs 5% | 26% |
| Decreased appetite | 33% vs 3% | 27% |
| Insomnia | 27% vs 13% | 27% |
| Headache | 26% vs 13% | — |
| Weight loss | 10% vs 0% | — |
The Vyvanse label lists decreased appetite, insomnia and dry mouth as its most frequent adult reactions, each well above placebo [2].
Methylphenidate-Based Medications
Includes: Ritalin (IR and LA), Concerta (OROS), Focalin (IR and XR), Daytrana (patch), Quillivant, Jornay PM, Azstarys, Cotempla.
Most common in adult Concerta trials (medicine vs placebo) [3]:
| Side Effect | Concerta |
|---|---|
| Decreased appetite | 25% vs 7% |
| Headache | 22% vs 16% |
| Dry mouth | 14% vs 4% |
The Concerta label also lists nausea, insomnia, anxiety, dizziness, weight loss and irritability among the adult reactions seen in at least 5% of people [3]. Other methylphenidate products have their own labels with their own figures, so check the one for your medicine.
Non-Stimulant Medications
Includes: Strattera (atomoxetine), Intuniv (guanfacine ER), Kapvay (clonidine ER), Qelbree (viloxazine).
Non-stimulants work through different mechanisms: norepinephrine reuptake inhibition (Strattera, Qelbree) or alpha-2 adrenergic agonism (Intuniv, Kapvay). NICE NG87 places them after stimulants in its usual order of treatment [7]. Strattera's side effects tend to come before its benefit; our atomoxetine timeline, week by week shows when each usually appears.
| Side Effect | Strattera, adults [4] | Intuniv, ages 6–17 [5] | Qelbree, adults [6] |
|---|---|---|---|
| Nausea | 26% vs 6% | 6% vs 2% | listed as common |
| Dry mouth | 20% vs 5% | 4% vs 1% | listed as common |
| Decreased appetite | 16% vs 3% | — | listed as common |
| Insomnia | 15% vs 8% | — | 23% vs 7% |
| Fatigue | 10% vs 6% | 14% vs 3% | listed as common |
| Somnolence | — | 38% vs 11% | listed as common |
| Low blood pressure | — | 7% vs 3% | — |
Intuniv is approved in the US for ages 6 to 17, so its figures come from children and teenagers [5]. Qelbree can raise heart rate and diastolic blood pressure [6]. Strattera and Qelbree both carry a boxed warning about suicidal thoughts [4][6].
Side Effects Reference Table by Medication
| Medication Class | Medication | Common side effects on the label | Label warnings to know about |
|---|---|---|---|
| Amphetamine | Adderall XR | Dry mouth, ↓ appetite, insomnia, headache, weight loss [1] | Raised BP and HR, psychosis or mania, misuse |
| Amphetamine | Vyvanse | ↓ appetite, insomnia, dry mouth [2] | Raised BP and HR, psychosis or mania, misuse |
| Methylphenidate | Concerta | ↓ appetite, headache, dry mouth, nausea, insomnia [3] | Raised BP and HR, priapism, misuse |
| Non-stimulant | Strattera | Nausea, dry mouth, ↓ appetite, insomnia [4] | Suicidal thoughts (boxed), liver injury, priapism |
| Non-stimulant | Intuniv (guanfacine) | Somnolence, fatigue, low BP [5] | Rebound high blood pressure if stopped abruptly |
| Non-stimulant | Qelbree (viloxazine) | Insomnia, headache, somnolence, fatigue, nausea [6] | Suicidal thoughts (boxed), raised HR and BP |
Detailed Side Effect Guide
Appetite Suppression and Weight Loss
Frequency: Decreased appetite was reported by 33% of adults on Adderall XR, 27% on Vyvanse and 25% on Concerta in the label trials [1][2][3]. The stimulant labels also warn about weight loss and slowed growth in children [2].
When it appears: Many people notice it while the medicine is active and find their appetite comes back as it wears off. A log of meal times against dose times shows your own pattern.
What can help:
- Planned eating: Some people set reminders for meals and snacks because hunger cues are unreliable on medication days.
- Easy food: Keeping low-effort options around (yogurt, shakes, cheese, nuts) makes it easier to eat when appetite is low.
- Morning and evening: Many people find the hours before the dose takes effect and the evening after it fades are when eating is easiest. Whether eating before your dose suits your medicine is a question for your prescriber or pharmacist.
- When to contact your prescriber:
- You are losing weight you did not intend to lose
- You are regularly skipping meals because you can't eat
- Any signs of disordered eating
- In children: growth or weight dropping away from their usual track
Insomnia and Sleep Disturbance
Frequency: Insomnia was reported by 27% of adults on Adderall XR (13% on placebo) and 27% on Vyvanse [1][2]. A meta-analysis of studies in children found stimulants lengthened the time to fall asleep and shortened total sleep [8].
When it appears: Trouble falling asleep is the usual pattern, and it can start early in treatment.
What the labels say: Vyvanse is to be taken in the morning, and the label says to avoid afternoon doses because of the potential for insomnia [2]. Adderall XR is given on waking, and the label says afternoon doses should be avoided for the same reason [1]. Jornay PM is the exception: it is taken in the evening and releases very little drug in the first 10 hours [9].
What can help:
- Ask about timing: If sleep is a problem, ask your prescriber whether dose timing or formulation could change. Log the time you take each dose so that conversation has data behind it.
- Sleep routine: A regular bedtime and wake time, less screen time before bed and less caffeine later in the day are standard sleep-hygiene advice.
- When to contact your prescriber:
- Poor sleep is lasting more than a week or two
- Lost sleep is wiping out the daytime benefit
- You are thinking about a sleep aid (melatonin, antihistamines or prescription sleep medicine). Tell your prescriber and pharmacist before you start one.
For how stimulants change sleep, why ADHD sleep timing runs late, and what to log at night, see our full guide to ADHD medication and sleep.
Dry Mouth
Frequency: 35% of adults on Adderall XR, 26% on Vyvanse, 14% on Concerta and 20% on Strattera in the label trials [1][2][3][4].
When it appears: Usually while the medicine is active.
What can help:
- Sipping water through the day
- Sugar-free gum or lozenges
- A dry-mouth rinse from the pharmacy
- Telling your dentist you take the medicine, since a dry mouth raises the risk of tooth decay
- When to contact your prescriber: if dry mouth is causing dental problems or makes swallowing difficult
Headache
Frequency: 26% of adults on Adderall XR (13% on placebo) and 22% on Concerta (16% on placebo) [1][3].
When it appears: Many people notice headaches early in treatment or after a dose change. Logging the time a headache starts against your dose time shows whether it lines up with the peak or with the wear-off.
What can help:
- Water and food: Low appetite can mean less eating and drinking, and both can bring on headaches.
- Pain relief: Ask your pharmacist which over-the-counter pain relief is safe with your medicine.
- When to contact your prescriber:
- Headaches keep coming after the first couple of weeks
- You are needing pain relief most days
- Seek urgent care for a sudden, severe headache, or a headache with vision changes, confusion, weakness or trouble speaking
Anxiety and Jitteriness
Frequency: Anxiety is among the adult reactions seen in at least 5% of people on the Concerta label [3]. In the 4-week Vyvanse trial in adults with ADHD, 6% reported anxiety and 4% felt jittery, against 0% on placebo [2].
When it appears: It can start with the first doses. Some people notice it around the peak, and others notice irritability or low mood as the dose wears off.
What can help:
- Review the plan with your prescriber: Dose-related side effects are often addressed by your prescriber adjusting the dose or the pace of titration. Never change the dose yourself.
- Caffeine: Caffeine also raises heart rate and can make jitteriness worse. Logging how much you drink lets you and your prescriber see whether it lines up with the anxious days.
- Existing anxiety: If you have a history of generalized anxiety, panic disorder, or social anxiety, tell your prescriber. These conditions may need treatment alongside ADHD medication.
- When to contact your prescriber:
- Anxiety is getting in the way of work, study or daily life
- You have panic attacks
- Anxiety keeps going past the first couple of weeks
- You are avoiding people or work because of it
Cardiovascular Effects
Frequency: The stimulant labels say these medicines raise blood pressure by about 2 to 4 mmHg and heart rate by about 3 to 6 beats per minute on average, and that some people have larger increases [2]. Qelbree can raise heart rate and diastolic blood pressure [6]. Intuniv can lower blood pressure and heart rate [5].
When it appears: While the medicine is active, for as long as you take it. The labels ask prescribers to check heart rate and blood pressure before starting, after dose increases and from time to time during treatment [2][6].
What can help:
- Baseline: Knowing your usual resting heart rate and blood pressure before you start makes later readings easier to read.
- Home readings: If your prescriber asks you to check at home, use a validated upper-arm cuff and measure at the same time of day so readings are comparable. Log them alongside your dose.
- When to contact your prescriber:
- Your readings are consistently higher than your prescriber said to expect, or above the thresholds they gave you
- You notice palpitations, dizziness, or a racing heart at rest
- You have a family history of heart problems or sudden death that you haven't mentioned. The American Heart Association statement on stimulants and heart disease covers how prescribers assess this [10]
- Emergency (call 911 or your local number): chest pain, severe shortness of breath, fainting, or an irregular heartbeat
Gastrointestinal Issues
Includes nausea, abdominal pain, diarrhea, and constipation.
Frequency: Nausea is more prominent with Strattera (26% of adults vs 6% on placebo) than with the stimulants in these labels [4]. In children on Strattera, abdominal pain was 18% vs 10% [4]. Nausea and constipation are among the common adult reactions on the Qelbree label [6].
What can help:
- Ask your pharmacist whether your medicine can be taken with food. Most of these labels allow it, and the label for your medicine is the place to check.
- Constipation can follow from eating and drinking less, so food and water intake are worth logging too.
- When to contact your prescriber: nausea that doesn't settle, repeated vomiting, or severe abdominal pain
Emotional Blunting
Frequency: Emotional blunting is not reported as a separate item in these label tables, so there is no reliable figure for how common it is.
What it feels like: People describe feeling flat, less spontaneous, or "not themselves", while still alert. It is different from sleepiness.
What can help:
- Review the plan with your prescriber: Log when it happens and how it feels. Your prescriber may consider a change to the dose, timing or medicine. Never change your dose yourself.
- When to contact your prescriber:
- It is affecting your relationships or quality of life
- You have felt "like a robot" or "not yourself" for more than a couple of weeks
- You are losing interest or pleasure in things, which can also be a sign of depression
Tics and Tremors
What the evidence says: A meta-analysis of trials in children with ADHD and tic disorders found that stimulants did not, as a group, worsen tics compared with placebo, though individual children can react differently [11]. Tics are listed in the stimulant labels as a possible reaction.
What can help:
- Document baseline: If you or your child already has tics, a short note or video of how often they happen before starting gives a reference point.
- Talk to the prescriber about options: Dose, timing and medicine choice are all decisions for your prescriber.
- When to contact your prescriber:
- New or worse tics that are getting in the way of daily life
- A tremor that makes writing, typing or eating hard
Crash and Rebound
What it is: As a dose wears off, some people feel irritable, tired, low or hungry, and ADHD symptoms come back. The labels do not give a rate for this, and published estimates vary a lot, so we don't quote one.
When it appears: Toward the end of the dose, which is earlier with short-acting medicines and later with long-acting ones. The time on your log when it starts is the most useful thing to bring.
Common signs:
- Irritability
- Fatigue
- Low mood
- Strong hunger after a day of low appetite
- ADHD symptoms coming back
- Emotional sensitivity
What can help:
- Write down when it starts: A log of the time the crash begins, against your dose time, shows your prescriber whether coverage ends earlier than you need.
- Ask about options: Prescribers sometimes change the formulation, the timing or add a second dose. That is their decision, based on your pattern.
- Food: The crash often comes when appetite returns, so a planned meal around that time may help with the hunger part.
- When to contact your prescriber:
- The crash is getting in the way of work, family, or social life every day
- Mood changes during the crash feel severe or frightening
For Vyvanse and Elvanse specifically, see our guide to the afternoon crash.
Rare but Serious Side Effects
The following events are uncommon, but the labels list them because a quick response matters.
Psychosis and Mania
Frequency: In a pooled analysis of short-term trials described in the stimulant labels, new psychotic or manic symptoms occurred in about 0.1% of stimulant-treated patients and 0% of those on placebo [2]. An FDA review of trial and postmarketing reports in children found that most cases happened in children with no earlier history of these symptoms [12].
Presentation: Paranoid thoughts, hearing or seeing things others don't, disorganized behaviour, or mania (grandiosity, little need for sleep, pressured speech, risky behaviour).
Risk factors: The labels ask prescribers to screen for a personal or family history of bipolar disorder before starting a stimulant [2].
When to act: If you or someone close to you notices you're hearing or seeing things others don't, having paranoid thoughts, or behaving in ways that seem out of character (grandiose plans, extreme irritability, decreased need for sleep), contact your prescriber immediately. If safety is a concern, go to the nearest emergency department.
Seizures
What the labels say: Seizures appear in the Vyvanse label among postmarketing reports and as a possible effect of overdose [2]. If you have epilepsy or have had seizures, tell your prescriber before starting.
When to act: Any new seizure is a medical emergency. Call 911 (or your local emergency number) or go to the nearest emergency department.
Priapism
What it is: A painful or painless erection lasting more than 4 hours. The FDA warned in 2013 that methylphenidate products can rarely cause it, noted it is also linked to atomoxetine, and said it does not know how often it happens [13]. Some reported cases came after a dose increase and some during a break from the medicine [13]. The Strattera label says prompt medical attention is required if it is suspected [4].
Note: This can affect males of any age, including children.
When to act: Any erection lasting longer than 4 hours is a medical emergency. Go to the nearest emergency department straight away.
Serious Cardiovascular Events
What the labels say: Sudden death has been reported in people with structural heart abnormalities or other serious heart disease who took stimulants at the usual ADHD dose [2]. This is why prescribers ask about heart symptoms and family history before starting.
Risk factors the labels and the American Heart Association statement point to: structural heart disease, cardiomyopathy, serious arrhythmias, coronary artery disease, and a family history of sudden death [2][10].
When to act: Chest pain, fainting, severe shortness of breath, an irregular heartbeat, or sudden collapse: call 911 or your local emergency number immediately.
When to Push Through vs. When to Contact Your Prescriber
This table is a summary of the advice above. Your prescriber may give you different thresholds, and theirs come first.
| Symptom | Log it and mention it at review | Contact prescriber | Emergency (call 911) |
|---|---|---|---|
| Decreased appetite | Yes | Weight loss you didn't intend | — |
| Trouble falling asleep | Yes | Lasting more than a week or two | — |
| Dry mouth | Yes | Dental problems, trouble swallowing | — |
| Headache, mild | Yes | Persistent, or needing pain relief most days | Sudden severe headache, vision changes or confusion |
| Anxiety, mild | Yes | Panic attacks, getting in the way of life | — |
| Heart rate or BP higher | Yes (log readings) | Above the thresholds your prescriber gave you | Chest pain, fainting |
| Jitteriness or tremor | Yes | Getting in the way of daily tasks | — |
| Emotional blunting | Yes | More than a couple of weeks, affecting relationships | — |
| Crash or rebound | Yes (log the time) | Daily disruption | — |
| New tics | — | Yes | — |
| Psychotic symptoms | — | Immediately | If safety is a concern |
| Seizure | — | — | Immediately |
| Erection over 4 hours | — | — | Immediately |
| Chest pain | — | — | Immediately |
FAQ
Q: How long do side effects typically last before my body adjusts?
A: It varies by person and by side effect. Many people find some early effects, like headache or jitteriness, ease over the first weeks, but the labels don't promise that. The labels say heart rate and blood pressure rises continue while you take the medicine. If a side effect hasn't improved after a couple of weeks, bring your log to your prescriber rather than waiting it out.
Q: Can I take medication breaks to reduce side effects?
A: Only with your prescriber's agreement. NICE NG87 asks for ADHD medication to be reviewed at least once a year, including whether it should continue, and some people agree planned breaks with their prescriber. The rules differ by medicine: the Strattera label says no taper is needed when stopping, while the Intuniv label warns that stopping abruptly can cause a rebound rise in blood pressure and says to taper. Ask your prescriber before skipping or stopping any doses.
Q: Do different formulations of the same medication have different side-effect profiles?
A: They can. The same active drug released at a different speed gives a different blood-level curve over the day, which can change when side effects show up and how strong they feel. If one version doesn't suit you, ask your prescriber whether another formulation is an option.
Q: Are generic stimulants as effective as brand-name?
A: In the US, a generic has to show bioequivalence to the brand in FDA testing. Some people still report a different experience after a switch, especially with extended-release products. If you notice a change after the pharmacy switches your brand or generic, log it and tell your prescriber and pharmacist.
Q: Do side effects mean the medication is "too strong"?
A: Not necessarily. Some side effects (mild appetite suppression, brief sleep onset delay, dry mouth) are expected and are common early on. Other side effects (anxiety, emotional blunting, significant insomnia, jitteriness) are worth logging and raising with your prescriber, and may also indicate that the medication class isn't right for you. Never change your dose yourself, and seek urgent care for chest pain, fainting, or a severe mood change. The key is whether the benefits clearly outweigh the side effects after an adequate trial, which your prescriber can help you judge.
Q: If I have a rare side effect, should I stop taking ADHD medications entirely?
A: That depends on what happened, and it is a decision for your prescriber or a specialist. Some labels say what to do: Strattera should be stopped and not restarted after jaundice or signs of liver injury. Get urgent help for the emergencies listed above, and don't stop or restart a medicine on your own.
Q: I'm in my 30s. Should I be worried about my heart on stimulants?
A: The labels say stimulants raise heart rate and blood pressure a little on average, and that sudden death has been reported in people with serious existing heart disease. That's why your prescriber asks about heart symptoms and family history before starting, and checks blood pressure and heart rate during treatment. If you have high blood pressure, heart disease, or a family history of sudden death, tell them.
Key Takeaways
The common side effects are on the label. Decreased appetite, insomnia, dry mouth and headache each affected roughly a quarter to a third of adults in the Adderall XR and Vyvanse trials.
Heart rate and blood pressure stay up while you take a stimulant. The average rise is small, some people have larger increases, and the labels ask for checks before and during treatment.
A log beats memory. Writing down what you noticed and when gives your prescriber a clearer picture than a recollection at the appointment.
Rare side effects are real. Psychosis, mania, seizures, priapism, and serious heart events are uncommon but need immediate action. Know the warning signs.
One medicine not suiting you doesn't mean none will. Your prescriber can consider another dose, formulation or class.
Never adjust your dose alone. Whether an effect will settle or needs a change is a call for your prescriber.
Take Control of Your Titration
The most important variable in managing side effects is data: knowing what you're experiencing, when, and at what dose.
Titrate is built around this: one-tap side-effect logging, dose tracking, and a one-page report your prescriber can scan in seconds. Instead of showing up saying "I think it's going okay," you arrive with two weeks of notes showing how each dose went.
→ Start tracking your side effects with Titrate ←
→ Generate your prescriber report ←
→ Learn how prescribers use structured data for titration decisions ←
References
- FDA prescribing information — Adderall XR (mixed amphetamine salts) extended-release capsules, sections 2, 6, 7 and 12.3. DailyMed: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aff45863-ffe1-4d4f-8acf-c7081512a6c0
- FDA prescribing information — Vyvanse (lisdexamfetamine dimesylate), sections 2, 5, 6 and 12.3. DailyMed: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=704e4378-ca83-445c-8b45-3cfa51c1ecad
- FDA prescribing information — Concerta (methylphenidate HCl) extended-release tablets, sections 2, 6 and 7. DailyMed: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd
- FDA prescribing information — Strattera (atomoxetine), sections 2, 5 and 6. DailyMed: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=309de576-c318-404a-bc15-660c2b1876fb
- FDA prescribing information — Intuniv (guanfacine extended-release), sections 1, 2, 5 and 6. DailyMed: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b972af81-3a37-40be-9fe1-3ddf59852528
- FDA prescribing information — Qelbree (viloxazine extended-release), boxed warning and sections 5 and 6. DailyMed: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aedf408d-0f84-418d-9416-7c39ddb0d29a
- NICE guideline NG87: Attention deficit hyperactivity disorder: diagnosis and management. https://www.nice.org.uk/guidance/ng87
- Kidwell KM, et al. Stimulant medications and sleep for youth with ADHD: a meta-analysis. Pediatrics. 2015;136(6):1144-1153.
- FDA prescribing information — Jornay PM (methylphenidate HCl) extended-release capsules, sections 2 and 12.3. DailyMed: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d95dede0-b1ff-4489-8f91-3bbe122852bf
- Vetter VL, et al. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder: a scientific statement from the American Heart Association. Circulation. 2008;117(18):2407-2423.
- Bloch MH, et al. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 2009;48(9):884-893.
- Mosholder AD, et al. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children. Pediatrics. 2009;123(2):611-616.
- FDA Drug Safety Communication (17 December 2013): FDA warns of rare risk of long-lasting erections in males taking methylphenidate ADHD medications. https://web.archive.org/web/20260310072954/https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-risk-long-lasting-erections-males-taking
This article is for educational purposes only. Side-effect rates are taken from the current US prescribing information; check the label for your own medicine and consult your healthcare provider for personal medical decisions.